Back to search
FDAFDA · Food and drugs·Recall number D-296-2013

Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India ;Marketed by Jubilant Cadista Pharmaceuatical Inc Salisbury, MD 21801 NDC 59746-284-90

Published May 8, 2013 · Recall initiated: February 11, 2013

Summary

FDA records drug Class II recall D-296-2013, published May 8, 2013 and initiated February 11, 2013. Recalling firm: Jubilant Cadista Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 12770 bottles; Lot: Lot PA22028 Exp 5/2014 Lot PA22029 Exp 5/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.

What to do

Voluntary: Firm initiated

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Jubilant Cadista Pharmaceuticals Inc.
Distributor
Nationwide
Lot
Lot PA22028 Exp 5/2014 Lot PA22029 Exp 5/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Pantoprazole Sodium Delayed Release Tablets USP, 40 mg, 90 count bottles, Manufactured by Jubilant Life Sciences Ltd, Roorkee-247661 India ;Marketed by Jubilant Cadista Pharmaceuatical Inc Salisbury, MD 21801 NDC 59746-284-90 recalled?

Yes. FDA published recall D-296-2013 on May 8, 2013. Reported hazard: cGMP Deviations: Oral products were not manufactured in accordance with Good Manufacturing Practices.

What should I do if I have this product?

Voluntary: Firm initiated